Donaldson Company, Inc. Q4 FY2025 earnings call

Management Statement and Operational Highlights

• Full-Year 2025: Record sales of $3.7 billion, operating profit margin 15.7%, EPS $3.68 (towards high end of guidance), returned $465M to shareholders via share repurchases and dividend increase. Focused on cost structure optimization and growth investments.
• Fourth Quarter 2025: Sales $981M (+5% y/y), adjusted EPS $1.03 (+10% y/y). Mobile solutions aftermarket strong, industrial solutions IFS grew, life sciences beverage and disk drive up. On-time delivery high, backlog supports outlook.
• Operational Highlights: Progressed on footprint and cost optimization, R&D and CapEx investments in solvent recovery, disk drive tech, and air/alternative fuels filtration; acquired RPS Associates of New England for dust collection services.

Segment Performance

• Mobile Solutions: Total sales were $588 million, a 2% increase vs prior year. Aftermarket sales were $468 million, up 3% due to strong OE channel demand and independent channel market share gains. First-fit off-road sales were $95 million, up 5%, while on-road sales were $26 million, down 20% due to cyclical truck production declines. China sales grew 14% y/y. Pretax profit margin was a record 19.1%, up 80 basis points y/y.
• Industrial Solutions: Industrial sales rose 8% to $310 million. IFS sales of $262 million grew 11% from new equipment sales in dust collection and power generation. Aerospace and defense sales were $47 million, down 6% due to completed large defense projects. Pretax margin was a record 20.9%, up 80 basis points y/y.
• Life Sciences: Sales of $82 million rose vs prior year. Double-digit growth in food and beverage and disk drive was partially offset by bioprocessing sales decline. Pretax margin improved to 5.3% from -1.2% y/y, driven by high-margin food/beverage and disk drive sales and cost structure optimization.

Guidance

• Fiscal 2026: Total sales midpoint $3.8 billion (1-5% growth), operating margin 16.1-16.7% (record), EPS $4 (midpoint $3.92-$4.08).
• Segment Specifics: Mobile solutions flat to +4% growth; industrial solutions +2-6% growth; life sciences mid-single-digit growth.
• Shareholder Returns: Dividend to increase for 30th consecutive year, share repurchase of 2-3% of outstanding shares planned.

Risks

• Tariffs: Plan to be profit dollar neutral over time, leveraging region-for-region footprint, USMCA qualification of Mexico shipments, and pricing muscle.
• Cyclical Headwinds: Continued caution in China market; cyclical declines in global truck production affecting on-road sales.
• Bioprocessing Delays: Delayed commercialization of bioprocessing solutions, with revenue growth more likely in 2027 as products are tested and brought to market.

Q: Tim Fine asked about reshoring/reindustrialization and project quoting pipeline.

A: Todd Carpenter stated sales teams in industrial segment are doing well, quote backlog is solid, and no abatement in project activity.